Prevention of Hypergranulation Tissue After Gastrostomy Tube Placement

Ann & Robert H Lurie Children's Hospital of Chicago171 enrolled

Overview

The primary objective of this study is to compare the incidence of postoperative hypergranulation tissue formation after gastrostomy tube placement among children randomized to one of three treatments, in addition to measuring tube dislodgements and rates of resource utilization for complications.

Hypergranulation tissue is one of the major immediate complications of gastronomy tube placement. This study aims to determine if using a foam dressing upon placement will prevent its formation, as it has been demonstrated as an effective treatment in healing hypergranulation tissue formation post-operatively. Study participants will be randomized into one of three treatments after gastronomy tube placement (1) standard care, (2) plain foam treatment or (3) silver foam dressing. These treatments will be applied for 30 days post-operatively in addition to standard care of cleaning the gastronomy site daily with soap and water, if assigned to foam intervention. All study materials are free for duration of 30 day intervention and participation will not interfere with routine post-operative care of gastronomy tube site. The total duration of trial will be 6 months and will not require additional study visits outside of routine care. The rate of G-tube dislodgements and associated outcomes will also be measured during the trial.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

PREVENTION

Masking

NONE

Enrollment

171

Conditions

Soft Tissue Inflammation

Interventions

Standard Hydrocolloid DressingPROCEDURE

Treatment placed over insertion site.

Silver Hydrocolloid DressingPROCEDURE

Place dressing against skin under gastrostomy tube

Eligibility

Sex: ALLMin age: 1 MonthMax age: 17 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Children between 1 month and 17 years of age who undergo gastrostomy tube placement by a member of the pediatric surgery faculty at Children's Memorial Hospital will be eligible for inclusion in this study. Exclusion Criteria: * Children undergoing gastrostomy tube placement by gastroenterology or interventional radiology at Children's Memorial Hospital. * Mother or caregiver of the patient is currently pregnant, breastfeeding and/or planning on getting pregnant within the next 60 days (silver HD has not been studied in pregnant or breastfeeding women)

Locations (1)

Children's Memorial Hospital

Chicago, Illinois, United States

Outcomes

Primary Outcomes

The primary outcome is to measure change in Hypergranulation tissue formation around Gastrostomy tube.

Time frame: 2 time points: 2 weeks and 6 months post insertion.

Secondary Outcomes

The secondary outcome is to measure change in visual assessment of postoperative condition of gastrostomy tube insertion site.

Time frame: 2 timepoints: 2 weeks and 6 months post insertion.

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.